The system is expected to come online by the end of the year. Its early users will include healthcare researchers at GSK, AstraZeneca, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, King\u2019s College London, and Oxford Nanopore Technologies.<\/p>\n \u201cTackling the world\u2019s most pressing challenges in healthcare requires massively powerful computing resources to harness the capabilities of AI,\u201d said Nvidia founder and CEO Jensen Huang in his <\/span>GPU Technology Conference keynote<\/u><\/a>.<\/p>\n \u201cThe Cambridge-1 supercomputer will serve as a hub of innovation for the UK, and further the groundbreaking work being done by the nation\u2019s researchers in critical healthcare and drug discovery.\u201d<\/p>\n [Read: Are EVs too expensive? Here are 5 common myths, debunked<\/a>]<\/em><\/p>\n The system will have four key focus areas: joint industry research into large-scale healthcare and data-science problems; support for AI startups; compute time for university studies on medical cures; and education for future AI practitioners.<\/p>\n It will eventually form a part of an AI Center of Excellence that Nvidia plans to create in Cambridge alongside Arm, the British chip designer that the US firm recently agreed to buy for $40 billion<\/a>.<\/p>\n Published October 5, 2020 \u2014 16:31 UTC <\/p>\n![](\"https:\/\/cdn0.tnwcdn.com\/wp-content\/blogs.dir\/1\/files\/2020\/10\/Screenshot-2020-10-05-at-15.58.51.png\")